These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19119512)

  • 61. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR; Dale RA; Creager MA; Lipicky RJ; Constant J; Campbell LA; Hiatt WR
    Circulation; 2009 Jan; 119(3):452-8. PubMed ID: 19139383
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Factors associated with tuberculosis treatment non-compliance in Antananarivo city, Madagascar].
    Rakotonirina el-CJ; Ravaoarisoa L; Randriatsarafara FM; Rakotomanga Jde D; Robert A
    Sante Publique; 2009; 21(2):139-46. PubMed ID: 19476664
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Influence of garlic moxibustion on the therapeutic effect in re-treatment patients of tuberculosis].
    Zhao XP; Chen RX; Lü HQ
    Zhongguo Zhen Jiu; 2009 Jan; 29(1):10-2. PubMed ID: 19186714
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical use of rifabutin, a rifamycin-class antibiotic, for the treatment of tuberculosis (A supplement to the 2008 revision of "Standards for tuberculosis care").
    ;
    Kekkaku; 2011 Jan; 86(1):43. PubMed ID: 21401006
    [No Abstract]   [Full Text] [Related]  

  • 65. [Pharmacoeconomic model of the use of rifabutin in new cases of pulmonary tuberculosis].
    Mednikov BL; Plaksin DI; Piiavskiĭ SA
    Probl Tuberk; 2002; (9):13-7. PubMed ID: 12524980
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.
    Goldberg SV; Hanson D; Peloquin CA
    Clin Infect Dis; 2003 Aug; 37(4):607-8. PubMed ID: 12905149
    [No Abstract]   [Full Text] [Related]  

  • 67. [Skin discoloration].
    Ouzaid I; Lepeule R; Finke E; Pacanowski J; Cochen V; Tiev K; Fardet L; Cabane J; Kettaneh A
    Rev Med Interne; 2006 Oct; 27(10):787-8. PubMed ID: 16949705
    [No Abstract]   [Full Text] [Related]  

  • 68. [Application of rifabutin, a rifamycin-group antibiotic, to patients with tuberculosis].
    Kekkaku; 2008 Oct; 83(10):679. PubMed ID: 19119512
    [No Abstract]   [Full Text] [Related]  

  • 69. Rifabutin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):145-7. PubMed ID: 18486056
    [No Abstract]   [Full Text] [Related]  

  • 70. Drug-induced lupus associated with rifabutin: a literature review.
    Anyimadu H; Saadia N; Mannheimer S
    J Int Assoc Provid AIDS Care; 2013; 12(3):166-8. PubMed ID: 23442494
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rifalazil.
    Tuberculosis (Edinb); 2008 Mar; 88(2):148-50. PubMed ID: 18486057
    [No Abstract]   [Full Text] [Related]  

  • 72. Cycloserine.
    Tuberculosis (Edinb); 2008 Mar; 88(2):100-1. PubMed ID: 18486041
    [No Abstract]   [Full Text] [Related]  

  • 73. Rifapentine.
    Tuberculosis (Edinb); 2008 Mar; 88(2):155-8. PubMed ID: 18486059
    [No Abstract]   [Full Text] [Related]  

  • 74. Fighting tuberculosis: old drugs, new formulations.
    Blasi P; Schoubben A; Giovagnoli S; Rossi C; Ricci M
    Expert Opin Drug Deliv; 2009 Sep; 6(9):977-93. PubMed ID: 19678791
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.